Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a 4.115\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a: Cc1onc(C(=O)NC2CCCCC2)c1[N+](=O)[O-]
b: OCCN1CCN(Cc2nc(-c3cccc(Cl)c3)no2)CC1
Answer: a. Cc1onc(C(=O)NC2CCCCC2)c1[N+](=O)[O-]
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1onc(C(=O)NC2CCCCC2)c1[N+](=O)[O-]
Cc1onc(C(=O)NC2CCCCC2)c1[N+](=O)[O-]
[3-(cyclohexylcarbamoyl)-5-methyl-1,2-oxazol-4-yl]-oxido-oxoazanium